This provides convincing genetic evidence to demonstrate that the ataxia phenotype manifesting in human SCA22 patients and in heterozygous KI/+ mice is not caused by haploinsufficiency, but rather by Kcnd3 F227del being a dominant‐negative mutation. Here, KCND3 is linked to Ataxia.